Update as of 13 March 2025: The public consultation and appeals period for the HTA Council’s Preliminary Recommendation on the (1) High-Risk Human Papillomavirus (HrHPV) DNA Test and (2) Visual Inspection with Acetic Acid (VIA) for cervical cancer screening in women aged 30–65 years ended on 25 February 2025. HTA Philippines received and processed one continue reading : HTA Council Preliminary Recommendation on High-risk Human Papillomavirus (HPV) DNA Test and Visual Inspection with Acetic Acid
CALL FOR PROPOSALS: HTA Research Agenda Program [HTA Research Topics 2024 – Batch 3 & 4 [REPOST of FEC topics and Cycle 1 topics for Economic Assessments]
Published 16 January 2025 This call consists of prioritized health technology topics that underwent clinical assessment under the HTA general track and are proceeding to economic assessment which includes economic evaluation (EE), budget impact analysis (BIA), and household financial impact (HFI) analysis to assess both the value for money of a health technology and its continue reading : CALL FOR PROPOSALS: HTA Research Agenda Program [HTA Research Topics 2024 – Batch 3 & 4 [REPOST of FEC topics and Cycle 1 topics for Economic Assessments]
HTA Council Preliminary Recommendation on Abacavir/Lamivudine Tablet, Levonorgestrel Intrauterine Delivery (IUD) System, Levonorgestrel Subdermal Implant, Multiple Micronutrient Supplement Capsule, and Sodium Chloride + Potassium Chloride + Calcium Lactate Pentahydrate Powder for Reconstitution
Update as of 25 November 2024 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Abacavir/Lamivudine Tablet, Levonorgestrel Intrauterine Delivery (IUD) System, Levonorgestrel Subdermal Implant, Multiple Micronutrient Supplement Capsule, and Sodium Chloride + Potassium Chloride + Calcium Lactate Pentahydrate Powder for Reconstitution ended on 22 November 2024 without valid appeals received, this continue reading : HTA Council Preliminary Recommendation on Abacavir/Lamivudine Tablet, Levonorgestrel Intrauterine Delivery (IUD) System, Levonorgestrel Subdermal Implant, Multiple Micronutrient Supplement Capsule, and Sodium Chloride + Potassium Chloride + Calcium Lactate Pentahydrate Powder for Reconstitution
HTA Council Preliminary Recommendation on Dapivirine Vaginal Ring, Donepezil Hydrochloride, Tenofovir/Lamivudine/Dolutegravir and Tenofovir + Lamivudine in combination with Dolutegravir
Update as of 06 November 2024 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Dapivirine Vaginal Ring, Donepezil Hydrochloride, Tenofovir/Lamivudine/Dolutegravir and Tenofovir + Lamivudine in combination with Dolutegravir ended on 05 November 2024 without appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to the Secretary of continue reading : HTA Council Preliminary Recommendation on Dapivirine Vaginal Ring, Donepezil Hydrochloride, Tenofovir/Lamivudine/Dolutegravir and Tenofovir + Lamivudine in combination with Dolutegravir
HTA Council Preliminary Recommendation on Citicoline For Ischemic Stroke
Update as of 10 October 2024 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Citicoline for Ischemic Stroke ended on 09 October 2024 without appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to the Secretary of Health for decision. Published 25 continue reading : HTA Council Preliminary Recommendation on Citicoline For Ischemic Stroke